{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:33:30Z","timestamp":1791502410699,"version":"4.3.4"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":128,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rossy Family Foundation"},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Swiss Cancer League","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006505","name":"Swiss Re","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006505","name":"Swiss Re","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>CONCORD-3 highlighted wide disparities in population-based 5-year net survival for cutaneous melanoma during 2000\u20132014. Clinical evidence suggests marked international differences in the proportion of lethal acral and nodular subtypes of cutaneous melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to assess whether the differences in morphology may explain global variation in survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with melanoma were grouped into the following seven morphological categories: malignant melanoma, not otherwise specified (International Classification of Diseases for Oncology, third revision morphology code 8720), superficial spreading melanoma (8743), lentigo maligna melanoma (8742), nodular melanoma (8721), acral lentiginous melanoma (8744), desmoplastic melanoma (8745) and other morphologies (8722\u20138723, 8726\u20138727, 8730, 8740\u20138741, 8746, 8761, 8770\u20138774, 8780). We estimated net survival using the nonparametric Pohar Perme estimator, correcting for background mortality by single year of age, sex and calendar year in each country or region. All-ages survival estimates were standardized using the International Cancer Survival Standard weights. We fitted a flexible parametric model to estimate the effect of morphology on the hazard of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Worldwide, the proportion of nodular melanoma ranged between 7% and 13%. Acral lentiginous melanoma accounted for less than 2% of all registrations but was more common in Asia (6%) and Central and South America (7%). Overall, 36% of tumours were classified as superficial spreading melanoma. During 2010\u20132014, age-standardized 5-year net survival for superficial spreading melanoma was 95% or higher in Oceania, North America and most European countries, but was only 71% in Taiwan. Survival for acral lentiginous melanoma ranged between 66% and 95%. Nodular melanoma had the poorest prognosis in all countries. The multivariable analysis of data from registries with complete information on stage and morphology found that sex, age and stage at diagnosis only partially explain the higher risk of death for nodular and acral lentiginous subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides the broadest picture of distribution and population-based survival trends for the main morphological subtypes of cutaneous melanoma in 59 countries. The poorer prognosis for nodular and acral lentiginous melanomas, more frequent in Asia and Latin America, suggests the need for health policies aimed at specific populations to improve awareness, early diagnosis and access to treatment.<\/jats:p>\n                    <jats:p>What is already known about this topic? The histopathological features of cutaneous melanoma vary markedly worldwide. The proportion of melanomas with the more aggressive acral lentiginous or nodular histological subtypes is higher in populations with predominantly dark skin than in populations with predominantly fair skin.<\/jats:p>\n                    <jats:p>What does this study add? We aimed to assess the extent to which these differences in morphology may explain international variation in survival when all histological subtypes are combined. This study provides, for the first time, international comparisons of population-based survival at 5 years for the main histological subtypes of melanoma for over 1.5 million adults diagnosed during 2000\u20132014. This study highlights the less favourable distribution of histological subtypes in Asia and Central and South America, and the poorer prognosis for nodular and acral lentiginous melanomas. We found that later stage at diagnosis does not fully explain the higher excess risk of death for nodular and acral lentiginous melanoma compared with superficial spreading melanoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bjd.21274","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:54:35Z","timestamp":1648529675000},"page":"364-380","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1\u200a578\u200a482 adults diagnosed during 2000\u20132014 in 59 countries (CONCORD-3)"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-9526","authenticated-orcid":false,"given":"Veronica","family":"Di Carlo","sequence":"first","affiliation":[{"name":"Cancer Survival Group London School of Hygiene and Tropical Medicine Keppel Street WC1E 7HT London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Stiller","sequence":"additional","affiliation":[{"name":"National Disease Registration Service NHS Digital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Eisemann","sequence":"additional","affiliation":[{"name":"Institute of Social Medicine and Epidemiology, University of L\u00fcbeck Ratzeburger Allee 160 23538 L\u00fcbeck Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bordoni","sequence":"additional","affiliation":[{"name":"Ticino Cancer Registry, Dipartimento Sanit\u00e0 e Socialit\u00e0 Divisione della Salute Pubblica Via Ciseri 10 6600 Locarno Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Matz","sequence":"additional","affiliation":[{"name":"Cancer Survival Group London School of Hygiene and Tropical Medicine Keppel Street WC1E 7HT London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Curado","sequence":"additional","affiliation":[{"name":"Goi\u00e2nia Cancer Registry, Group of Epidemiology and Statistics on Cancer AC Camargo Cancer Center Rua Tamandar\u00e9 753 - Liberdade SP 01525-001 S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Daubisse-Marliac","sequence":"additional","affiliation":[{"name":"Tarn Cancer Registry Institut Universitaire du Cancer Toulouse \u2013 Oncopole Institut C. Regaud 1 Avenue Ir\u00e8ne Joliot-Curie 31059 Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Valkov","sequence":"additional","affiliation":[{"name":"Northern State Medical University Prospekt Troitskiy 51 163000 Arkhangelsk Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Bulliard","sequence":"additional","affiliation":[{"name":"Centre for Primary Care and Public Health (Unisant\u00e9) University of Lausanne Lausanne Switzerland"},{"name":"Neuch\u00e2tel and Jura Tumour Registry Neuch\u00e2tel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Morrison","sequence":"additional","affiliation":[{"name":"Scottish Cancer Registry Gyle Square, 1 South Gyle Crescent EH12 9EB Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Johnson","sequence":"additional","affiliation":[{"name":"Cancer Data Registry of Idaho, 615 North 7th Street ID 83701-1278 Boise USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Girardi","sequence":"additional","affiliation":[{"name":"Cancer Survival Group London School of Hygiene and Tropical Medicine Keppel Street WC1E 7HT London UK"},{"name":"Cancer Division University College London Hospitals NHS Foundation Trust Euston Road WC1H 8NJ London UK"},{"name":"Division of Medical Oncology 2 Veneto Institute of Oncology IOV-IRCCS Via Gattamelata 64 35128 Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Marcos-Gragera","sequence":"additional","affiliation":[{"name":"Epidemiology Unit and Girona Cancer Registry Catalan Institute of Oncology (ICO), IDIBGI, Oncology Coordination Plan, Department of Health Government of Catalonia 17004 Girona Spain"},{"name":"University of Girona (UdG) 17004 Girona Spain"},{"name":"CIBER of Epidemiology and Public Health (CIBERESP) Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"\u0160ekerija","sequence":"additional","affiliation":[{"name":"Croatian National Cancer Registry Croatian Institute of Public Health Rockefeller Street 7 10000 Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Lar\u00f8nningen","sequence":"additional","affiliation":[{"name":"Cancer Registry of Norway Ullernchausseen 64 0379 Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Sirri","sequence":"additional","affiliation":[{"name":"Epidemiological Cancer Registry of Lower Saxony Offis Caree GmbH Industriestr 92 6121 Oldenburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel P.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Cancer Survival Group London School of Hygiene and Tropical Medicine Keppel Street WC1E 7HT London UK"},{"name":"Cancer Division University College London Hospitals NHS Foundation Trust Euston Road WC1H 8NJ London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Allemani","sequence":"additional","affiliation":[{"name":"Cancer Survival Group London School of Hygiene and Tropical Medicine Keppel Street WC1E 7HT London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CONCORD Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"2023010808101400700_bjd21274-bib-0001","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.2910470402","article-title":"Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely","volume":"47","author":"van der Esch","year":"1991","journal-title":"Int J Cancer"},{"key":"2023010808101400700_bjd21274-bib-0002","volume-title":"Trends in Cancer Incidence and Mortality","author":"Coleman","year":"1993"},{"key":"2023010808101400700_bjd21274-bib-0003","volume-title":"Cancer Incidence in Five Continents","author":"Bray","year":"2017"},{"key":"2023010808101400700_bjd21274-bib-0004","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0190-9622(99)70251-3","article-title":"Clinicopathologic analysis of malignant melanoma in Taiwan","volume":"41","author":"Chen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10147-007-0751-1","article-title":"Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update","volume":"13","author":"Ishihara","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"2023010808101400700_bjd21274-bib-0006","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"2023010808101400700_bjd21274-bib-0007","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1186\/s12885-016-2963-0","article-title":"Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011","volume":"16","author":"Schoffer","year":"2016","journal-title":"BMC Cancer"},{"key":"2023010808101400700_bjd21274-bib-0008","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/ijc.30407","article-title":"Epidemiology of cutaneous melanoma in Sweden. Stage-specific survival and rate of recurrence","volume":"139","author":"Rockberg","year":"2016","journal-title":"Int J Cancer"},{"key":"2023010808101400700_bjd21274-bib-0009","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/cncr.24966","article-title":"Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis","volume":"116","author":"Xing","year":"2010","journal-title":"Cancer"},{"key":"2023010808101400700_bjd21274-bib-0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9610(98)00070-1","article-title":"Superior survival of young women with malignant melanoma","volume":"175","author":"Kemeny","year":"1998","journal-title":"Am J Surg"},{"key":"2023010808101400700_bjd21274-bib-0011","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/CEJ.0000000000000306","article-title":"Trends in net survival from skin malignant melanoma in six European Latin countries: Results from the SUDCAN population-based study","volume":"26","author":"Galceran","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"2023010808101400700_bjd21274-bib-0012","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/cam4.1152","article-title":"Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011","volume":"6","author":"Enninga","year":"2017","journal-title":"Cancer Med"},{"key":"2023010808101400700_bjd21274-bib-0013","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2015.07.039","article-title":"Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study","volume":"51","author":"Crocetti","year":"2015","journal-title":"Eur J Cancer"},{"key":"2023010808101400700_bjd21274-bib-0014","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jaad.2011.05.030","article-title":"Melanoma survival in the United States, 1992 to 2005","volume":"65","author":"Pollack","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.23495","article-title":"Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003","volume":"123","author":"Downing","year":"2008","journal-title":"Int J Cancer"},{"key":"2023010808101400700_bjd21274-bib-0016","first-page":"705","article-title":"The histogenesis and biologic behaviour of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"2023010808101400700_bjd21274-bib-0017","volume-title":"WHO Classification of Skin Tumours","author":"Elder","year":"2018","edition":"4th edn"},{"key":"2023010808101400700_bjd21274-bib-0018","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0046-8177(86)80030-2","article-title":"A unifying concept of malignant melanoma: biologic aspects","volume":"17","author":"Ackerman","year":"1986","journal-title":"Hum Pathol"},{"key":"2023010808101400700_bjd21274-bib-0019","volume-title":"International Classification of Diseases for Oncology","author":"Fritz","year":"2013","edition":"3rd edn"},{"key":"2023010808101400700_bjd21274-bib-0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Pohar Perme","year":"2012","journal-title":"Biometrics"},{"key":"2023010808101400700_bjd21274-bib-0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1536867X1401400107","article-title":"Net survival estimation with stns","volume":"14","author":"Clerc-Urm\u00e8s","year":"2014","journal-title":"Stata J"},{"key":"2023010808101400700_bjd21274-bib-0022","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#","article-title":"An alternative approach to monitoring cancer patient survival","volume":"78","author":"Brenner","year":"1996","journal-title":"Cancer"},{"key":"2023010808101400700_bjd21274-bib-0023","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"key":"2023010808101400700_bjd21274-bib-0024","volume-title":"Methodology: standard countries or area codes for statistical use (M49)","author":"United Nations Statistics Division"},{"key":"2023010808101400700_bjd21274-bib-0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata J"},{"key":"2023010808101400700_bjd21274-bib-0026","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"2023010808101400700_bjd21274-bib-0027","volume-title":"ENCR recommendation: Condensed TNM for Coding the Extent of Disease","author":"Berrino","year":"2002"},{"key":"2023010808101400700_bjd21274-bib-0028","volume-title":"SEER Summary Staging Manual 2000: Codes and Coding Instructions","author":"Young","year":"2001"},{"key":"2023010808101400700_bjd21274-bib-0029","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jnci\/djy086","article-title":"Primary melanoma histologic subtype: impact on survival and response to therapy","volume":"111","author":"Lattanzi","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2023010808101400700_bjd21274-bib-0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0031","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canep.2016.02.005","article-title":"The burden of cutaneous melanoma and status of preventive measures in Central and South America","volume":"44","author":"de Vries","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"2023010808101400700_bjd21274-bib-0032","first-page":"285","article-title":"Completeness of data on malignant melanoma skin sites and morphology in the Croatian National Cancer Registry 2000\u20132014: an overview of recent progress","volume":"25","author":"Barbari\u0107","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"key":"2023010808101400700_bjd21274-bib-0033","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.2011.38.8561","article-title":"Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"2023010808101400700_bjd21274-bib-0034","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.25996","article-title":"Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990\u20132006","volume":"130","author":"Baade","year":"2012","journal-title":"Int J Cancer"},{"key":"2023010808101400700_bjd21274-bib-0035","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.ejca.2009.03.004","article-title":"Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland","volume":"45","author":"Montella","year":"2009","journal-title":"Eur J Cancer"},{"key":"2023010808101400700_bjd21274-bib-0036","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/bjd.13483","article-title":"Trends in cutaneous malignant melanoma in Sweden 1997\u20132011: thinner tumours and improved survival among men","volume":"172","author":"Lyth","year":"2015","journal-title":"Br J Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0037","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bjps.2013.12.023","article-title":"Are we seeing the effects of public awareness campaigns? A 10-year analysis of Breslow thickness at presentation of malignant melanoma in the South West of England","volume":"67","author":"Armstrong","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2023010808101400700_bjd21274-bib-0038","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2017.12.024","article-title":"Trends in incidence of thick, thin and in situ melanoma in Europe","volume":"92","author":"Sacchetto","year":"2018","journal-title":"Eur J Cancer"},{"issue":"djv294","key":"2023010808101400700_bjd21274-bib-0039","article-title":"Melanoma thickness and survival trends in the United States, 1989 to 2009","volume":"108","author":"Shaikh","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"2023010808101400700_bjd21274-bib-0040","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s12094-018-1900-x","article-title":"Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994\u20132013: a population-based study","volume":"20","author":"Rubi\u00f3-Casadevall","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"2023010808101400700_bjd21274-bib-0041","first-page":"2019","volume-title":"50 Years of Cancer Registration (1968\u20132017)","author":"Singapore Cancer Registry"},{"key":"2023010808101400700_bjd21274-bib-0042","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13104-015-0972-8","article-title":"Melanoma characteristics in Brazil: demographics, treatment, and survival analysis","volume":"8","author":"Vazquez","year":"2015","journal-title":"BMC Res Notes"},{"key":"2023010808101400700_bjd21274-bib-0043","doi-asserted-by":"crossref","first-page":"31432","DOI":"10.1038\/srep31432","article-title":"Acral melanoma in Chinese: a clinicopathological and prognostic study of 142 cases","volume":"6","author":"Lv","year":"2016","journal-title":"Sci Rep"},{"key":"2023010808101400700_bjd21274-bib-0044","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/1346-8138.13834","article-title":"Acral lentiginous melanoma versus other melanoma: a single-center analysis in Japan","volume":"44","author":"Wada","year":"2017","journal-title":"J Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.clindermatol.2008.09.014","article-title":"Melanoma of the feet: misdiagnosed and misunderstood","volume":"27","author":"Albreski","year":"2009","journal-title":"Clin Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0046","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005","volume":"145","author":"Bradford","year":"2009","journal-title":"Arch Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0047","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaad.2009.08.047","article-title":"Effectiveness of a knowledge-based intervention for melanoma among those with ethnic skin","volume":"62","author":"Kundu","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0048","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(03)02091-7","article-title":"Advanced presentation of melanoma in African Americans","volume":"50","author":"Byrd","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0049","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006258","article-title":"Malignant melanoma in African\u2013Americans: a population-based clinical outcomes study involving 1106 African\u2013American patients from the Surveillance, Epidemiology, and End Results (SEER) Database (1988\u20132011)","volume":"96","author":"Mahendraraj","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2023010808101400700_bjd21274-bib-0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archdermatol.2011.264","article-title":"The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007","volume":"148","author":"Shaikh","year":"2012","journal-title":"Arch Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0051","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaad.2012.09.047","article-title":"Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia","volume":"68","author":"Mar","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0052","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000658-197812000-00004","article-title":"A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark\u2019s and Breslow\u2019s staging methods","volume":"188","author":"Balch","year":"1978","journal-title":"Ann Surg"},{"key":"2023010808101400700_bjd21274-bib-0053","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ssu.10020","article-title":"New TNM melanoma staging system: linking biology and natural history to clinical outcomes","volume":"21","author":"Balch","year":"2003","journal-title":"Semin Surg Oncol"},{"key":"2023010808101400700_bjd21274-bib-0054","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaad.2018.09.018","article-title":"A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype","volume":"80","author":"Brunssen","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2023010808101400700_bjd21274-bib-0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2018.01.084","article-title":"Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?","volume":"93","author":"Minicozzi","year":"2018","journal-title":"Eur J Cancer"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.21274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.21274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/187\/3\/364\/48528691\/bjd0364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/187\/3\/364\/48528691\/bjd0364.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T05:38:28Z","timestamp":1700372308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/187\/3\/364\/6966604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,1]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.21274","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"2021-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}